| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Tumor Biology and Epidemiology [X-C. X., R. L.], Thoracic/Head and Neck Medical Oncology [S. M. L., J. S. L., W. K. H.], and Biomathematics [J. J. L.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Department of Food Science and Human Nutrition, Michigan State University, East Lansing, Michigan 48824 [M. H. Z.]
Nuclear retinoic acid receptor ß (RAR-ß) expression decreases in human premalignant oral lesions (POLs). RAR-ß suppression could result from a decrease in the cellular level of retinoids because RAR-ß gene transcription is enhanced by retinoids. To explore this hypothesis, we compared the binding of a monoclonal antibody (mAb) against all-trans-retinoic acid (RA; anti-RA mAbs) to normal oral tissue and POLs. All 7 normal specimens stained positive with the antibody compared to only 20 of 43 POLs; similarly, 7 of 7 normal specimens contained RAR-ß mRNA compared to only 14 of 43 POLs. Twenty-four specimens were available before and after a 3-month treatment with 13-cis-RA in vivo. Anti-RA mAb binding to these specimens increased from 10 of 24 before to 22 of 24 after treatment, and the expression of RAR-ß mRNA increased from 7 of 24 before to 21 of 24 after treatment, respectively. There was a strong agreement between the binding of anti-RA mAbs and the expression of RAR-ß. Thus, we propose that the binding of anti-RA mAbs reflects the level of retinoids in the tissues and that this level is related strongly to RAR-ß expression.
1 This study was supported in part by USPHS Grant PO1 CA52051 from the National Cancer Institute, the Abell-Hanger Foundation Professorship (R. L.), a fellowship from the Houston Endowment (X-C. X.), United States Department of Agriculture Grant 93-37200-6285 (M. H. Z.), and the Michigan Agricultural Experiment Station (M. H. Z.).
2 To whom requests for reprints should be addressed, at Department of Tumor Biology-108, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 9/11/95. Accepted 10/19/95.
This article has been cited by other articles:
![]() |
Y. Kubo, T. Ohba, and N. Takahashi Proteins in Human Myeloid Leukemia Cell Line HL60 Reacting with Retinoic Acid Monoclonal Antibodies J. Biochem., September 1, 2008; 144(3): 349 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman, J. Sudbo, and W. K. Hong Oral Cancer Prevention and the Evolution of Molecular-Targeted Drug Development J. Clin. Oncol., January 10, 2005; 23(2): 346 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lotan A Crucial Role for Cellular Retinol-Binding Protein I in Retinoid Signaling J Natl Cancer Inst, January 5, 2005; 97(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
E. M. Youssef, D. Lotan, J.-P. Issa, K. Wakasa, Y.-H. Fan, L. Mao, K. Hassan, L. Feng, J. J. Lee, S. M. Lippman, et al. Hypermethylation of the Retinoic Acid Receptor-{beta}2 Gene in Head and Neck Carcinogenesis Clin. Cancer Res., March 1, 2004; 10(5): 1733 - 1742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Triano, L. B. Slusher, T. A. Atkins, J. T. Beneski, S. A. Gestl, R. Zolfaghari, R. Polavarapu, E. Frauenhoffer, and J. Weisz Class I Alcohol Dehydrogenase Is Highly Expressed in Normal Human Mammary Epithelium but not in Invasive Breast Cancer: Implications for Breast Carcinogenesis Cancer Res., June 15, 2003; 63(12): 3092 - 3100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gestl, M. D. Green, D. A. Shearer, E. Frauenhoffer, T. R. Tephly, and J. Weisz Expression of UGT2B7, a UDP-Glucuronosyltransferase Implicated in the Metabolism of 4-Hydroxyestrone and All-Trans Retinoic Acid, in Normal Human Breast Parenchyma and in Invasive and in Situ Breast Cancers Am. J. Pathol., April 1, 2002; 160(4): 1467 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi, X. Xu, D. Chen, R. Lotan, J. S. Morris, S. M. Fischer, and S. M. Lippman Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Esophageal Cancer Cells by Restoring 15-Lipoxygenase-1 Expression Cancer Res., June 1, 2001; 61(12): 4879 - 4884. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Wang, M. Marko, A. R. Dahl, K. S. Engelke, M. E. Placke, A. R. Imondi, J. L. Mulshine, and L. M. De Luca Topical Delivery of 13-cis-Retinoic Acid by Inhalation Up-Regulates Expression of Rodent Lung but not Liver Retinoic Acid Receptors Clin. Cancer Res., September 1, 2000; 6(9): 3636 - 3645. [Abstract] [Full Text] |
||||
![]() |
J. J. Lee, W. K. Hong, W. N. Hittelman, L. Mao, R. Lotan, D. M. Shin, S. E. Benner, X.-C. Xu, J. S. Lee, V. M. Papadimitrakopoulou, et al. Predicting Cancer Development in Oral Leukoplakia: Ten Years of Translational Research Clin. Cancer Res., May 1, 2000; 6(5): 1702 - 1710. [Abstract] [Full Text] |
||||
![]() |
Y. S. Kuppumbatti, I. J. Bleiweiss, J. P. Mandeli, S. Waxman, and R. Mira-y-Lopez Cellular Retinol-Binding Protein Expression and Breast Cancer J Natl Cancer Inst, March 15, 2000; 92(6): 475 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. McCaskill-Stevens, E. T. Hawk, P. J. Flynn, and S. M. Lippman National Cancer Institute-Supported Cancer Chemoprevention Research: Coming of Age J. Clin. Oncol., November 1, 1999; 17(90001): 53 - 62. [Full Text] [PDF] |
||||
![]() |
H. Qiu, W. Zhang, A. K. El-Naggar, S. M. Lippman, P. Lin, R. Lotan, and X.-C. Xu Loss of Retinoic Acid Receptor-{beta} Expression Is an Early Event during Esophageal Carcinogenesis Am. J. Pathol., November 1, 1999; 155(5): 1519 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-C. Xu, X. Liu, E. Tahara, S. M. Lippman, and R. Lotan Expression and Up-Regulation of Retinoic Acid Receptor-{beta} Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines Cancer Res., May 1, 1999; 59(10): 2477 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lotan Lung Cancer Promotion by ß-Carotene and Tobacco Smoke: Relationship to Suppression of Retinoic Acid Receptor-ß and Increased Activator Protein-1? J Natl Cancer Inst, January 6, 1999; 91(1): 7 - 9. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |